Stay updated on our progress in changing the landscape of ovarian cancer treatment options and outcomes.

presentation

Dec 16, 2022

Clinical Trial: Targeting the targets – investigating an innovative chemotherapy alternative

Two funded clinical trials, though different in their approach and focus, share a dedication to exploring innovative treatment pathways and a made-in-Canada pedigree.

presentation

Nov 29, 2022

Research knows no bounds

Ovarian Cancer Canada takes a multi-pronged approach to ensure that all types of the disease, even the rarest ones, are prioritized to ensure that everyone benefits from the best available science as quickly as possible.

presentation

Jun 17, 2022

Prize awarded to researcher whose ovarian cancer vaccines are in preclinical studies funded by Ovarian Cancer Canada

Qingchuan Zhao’s research awarded the 2022 Anita Unruh Prize from Ovarian Cancer Canada

presentation

Dec 7, 2021

Ovarian Cancer Canada and the Cancer Research Society invest $2.25 million

Ovarian Cancer Canada and the Cancer Research Society invest $2.25 million in ovarian cancer research: Funding for 10 new projects just announced

presentation

Aug 17, 2021

Harnessing the power of vaccines to treat ovarian cancer

Most of us have recently heard a great deal about how vaccines help protect against the serious effects of COVID-19. But did you know that vaccines can also be used to treat disease?

presentation

Jun 15, 2021

Enabling research on rare forms of ovarian cancer

Dr. Mark Carey is developing scientific models to advance research on low-grade serous cancer, a rare form of the disease.

presentation

Apr 6, 2021

IRICoR and Ovarian Cancer Canada announce $2.3M

IRICoR and Ovarian Cancer Canada announce $2.3M for development of new treatments for ovarian cancer

presentation

Mar 30, 2021

$1.35 million for ovarian cancer research

The Cancer Research Society and Ovarian Cancer Canada are proud to jointly launch a competition to fund some of Canada’s most promising research projects focused on ovarian cancer. The competition will award up to 6 grants, each totaling $225,000 over a two-year period.

presentation

Feb 23, 2021

The benefits of 3D models in ovarian cancer research

These will enable scientists to test new treatments, leading to new clinical trials, and ultimately improved outcomes for women with this disease.

Connect

with us

Have a question or want to speak with a team member?

Get in touch